INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Ensuring Reliable Clinical Trial Material Production
Formulation and pharmacy experts share their secrets for completing clinical trials and resolving issues that could impact your drug development program’s timeline.
-
How RFI/RFP Optimization Changes The Game
Selecting the right vendors can determine whether a clinical trial advances smoothly or stalls under budget overruns and delays.
-
Pay-By-Procedure Vs. Pay-By-Visit
Explore how a pay-by-procedure model can reshape site payments, enhance transparency, and reveal meaningful efficiencies across complex clinical trials.
-
The Defensiveness Trap In Vendor Selection And Management
In clinical research, sponsor–vendor relationships are often framed as negotiations. Yet while both sides want to achieve a successful study, the process often becomes a tug-of-war.
-
Biotech Delivers A Superior Patient And Site Experience3/4/2025
To become the sponsor of choice for sites and patients in congenital hyperinsulinism clinical trials, a small biotech company prioritized delivering a superior experience while streamlining operations.
-
How To Select The Right Bioanalysis CRO For Your Program11/3/2025
The right bioanalysis CRO accelerates progress, while the wrong one can derail outcomes. When every provider claims speed and credibility, how do you confidently choose the right partner?
-
5 Common Gaps Between Patient Referral And Screening That Derail Trials6/15/2026
Up to 40% of clinical trial referrals drop off before screening due to financial, logistical, and administrative hurdles. Streamlining coordination and easing patient burden can boost enrollment.
-
Investigator Databank And DQS: Welcoming New Consortium Members5/16/2025
Join the Data Query System consortium to access a comprehensive, collaborative platform that enhances clinical trial feasibility, site selection, and investigator engagement.
-
How NeuroKit® Helps Avoid False Negatives in Early CNS Development7/30/2026
Detecting subtle CNS effects early can reduce false negatives. Sensitive assessments strengthen confidence in pharmacodynamic signals and dose selection.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
TrialKit requires minimal training for quick deployment. Its open API integrates seamlessly with databases, ideal for fast patient registry studies and high-quality data.
-
Developing cutting-edge treatments for ovarian cancer requires specialized expertise and a people-first approach to research.
-
Navigating drug safety in the era of innovation-driven medicine
The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.
-
Early-phase clinical research experts, specialized in first-in-human trials, clinical pharmacology/NDA-enabling studies, and proof-of-concept studies.
-
Accelerate endocrinology and metabolic trials. Discover global regulatory strategies, decentralized models, and patient-centric recruitment data to optimize your clinical development.